We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Single Cell Analysis Market: Growth, Size, Share, and Trends

Report Code BT 4224
Published in May, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030)

Overview

The global single-cell analysis market, valued at US$3.55 billion in 2024, is forecasted to grow at a robust CAGR of 14.7%, reaching US$3.81 billion in 2025 and an impressive US$7.56 billion by 2030. Growth in this market can be attributed to factors such as the rising incidence of cancer and immunological disorders, technological developments in single-cell analysis products, the growing focus on the advancement of stem cell research, and the increasing focus on the biotechnology sector. However, the high cost of single-cell analysis products may hamper the growth of the market.

Single-Cell Analysis Market– Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Single-Cell Analysis Market

Asia Pacific

The growth of the Asia Pacific single-cell analysis market is primarily due to increasing research investments in cell-based research and the growing focus on the development of advanced therapies in the region.

Growth in this market is primarily driven by technological advancements in single-cell analysis products, the increasing prevalence of cancer, and the rising focus on personalized medicine.

The high growth potential of single-cell sequencing is likely to offer potential growth opportunities in the single-cell analysis market.

The high cost of single-cell analysis products is a key factor restraining the market growth.

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

Global Single-Cell Analysis Market Dynamics

DRIVER: Technological advancements in single-cell analysis products

Companies in the single-cell analysis market are increasingly focused on creating more affordable, technologically advanced, and user-friendly instruments. For example, in February 2024, 10X Genomics introduced the GEM-X technology, the next generation of its single-cell technology architecture, designed to enhance new assays within its Chromium platform. The first two products utilizing the new GEM-X technology are the Chromium GEM-X Single Cell Gene Expression v4 and the GEM-X Single Cell Immune Profiling v3 assays. In a similar vein, in April 2023, Standard BioTools unveiled a new imaging technology, the Hyperion XTi Imaging System, at the American Association for Cancer Research (AACR) meeting held in Orlando.

RESTRAINT: High cost of single-cell analysis products

Cell biology involves extensive research aimed at developing new therapies, such as stem cell and gene therapies. The instruments, reagents, and other products used in this research must be of high quality to achieve accurate results. The implementation of advanced single-cell analysis techniques largely depends on the cost of these instruments. Flow cytometers, microfluidic devices, and high-content screening systems equipped with advanced features typically come with a premium price tag. The advancements in various instruments have resulted in higher costs than previous-generation models, largely due to their expensive development process. For example, the ATTUNE NxT Flow Cytometer from Thermo Fisher Scientific Inc. is priced at USD 30,000, while the SMARTer ICELL8 cx Single-Cell System from Takara Bio Inc. costs USD 17,995.

 

OPPORTUNITY: High growth potential of single-cell sequencing

Single-cell sequencing (SCS) helps researchers to understand transcriptional randomness and cellular heterogeneity in more detail. Advancements in single-cell sequencing have improved the detection and analysis of infectious disease outbreaks, antibiotic drug-resistant strains, food-borne pathogens, and microbial diversity in the environment. As single-cell sequencing technology provides extensive details on genetic mutations, companies are focusing on developing instruments and reagents that are suitable for single-cell sequencers. For instance, Illumina, Inc. (US), one of the major players in the single-cell analysis market, offers integrated ultra-low-input and single-cell RNA sequencing workflows (with the SMARTer Ultra Low Input RNA Kit by US-based Clontech Laboratories Inc., combined with the Nextera XT DNA Library Preparation Kit and Illumina sequencing technology) that help in the simplification of the entire process, from library preparation to data analysis and biological interpretation. Considering the high-growth potential of this segment, several advanced SCS instruments are expected to be developed and launched in the market in the coming years.

CHALLENGES: Technical challenges associated with single-cell analysis

Despite varied applications and advantages of single-cell analysis, it may sometimes show irregular results as a result of technical limitations associated with the single-cell analysis technique. Some technical limitations of single-cell analysis include technological biases and amplification errors. Technological biases, such as amplification biases and batch effects, can affect the results of single-cell analysis. Amplification steps in single-cell analysis may introduce biases, leading to the uneven representation of transcripts and potential distortion of gene expression profiles. Also, variability between different experimental batches can impact the reproducibility and comparability of single-cell datasets. Therefore, technical challenges associated with single-cell analysis are expected to affect the growth of the market.

Global Single-Cell Analysis Market Ecosystem Analysis

The single-cell analysis market ecosystem comprises raw material suppliers, single-cell analysis product manufacturers, and end users, such as academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and cell banks & IVF centers. Single-cell analysis product manufacturers provide consumables and instruments.

Single-Cell Analysis Market
 

The human cells segment dominated the single-cell analysis market in 2024.

Based on cell type, the single-cell analysis market is segmented into human cells, animal cells, and microbial cells. In 2024, the human cells segment dominated the market owing to the growing applications of human stem cells for the development of cell-based therapies. Human stem cells are witnessing a significant surge in demand, primarily driven by increasing investments in cancer research activities across the globe. Considering ongoing developments such as rising funding allocations for cancer research initiatives, the demand for human stem cells in cancer research and related fields is anticipated to grow further over the coming years. Several biotechnology and pharmaceutical companies are actively investing in research activities to develop specialized stem cells that can be cultured, expanded, and utilized for various medical applications. Such advancements in research are expected to significantly support the growth of this market segment. Additionally, the technological innovations in single-cell analysis techniques are enhancing the accuracy and efficiency of cell-based research, contributing to greater adoption.

Animal cells held the second-highest market share, largely supported by increasing investments in animal research, veterinary medicine, and the development of veterinary therapeutics. This growth is further reinforced by the growing need for improved animal healthcare solutions.

The flow cytometry segment dominated the single-cell analysis market in 2024.

Based on technique, the single-cell analysis market is segmented into flow cytometry, next-generation sequencing, polymerase chain reaction (PCR), microscopy, mass spectrometry, and other emerging techniques. In 2024, the flow cytometry segment accounted for the largest share of the global market. This dominance is largely attributed to the growing emphasis on the development of cellular therapies, particularly in oncology and immunology, where flow cytometry plays a crucial role. Flow cytometry is extensively utilized for its ability to rapidly analyze the physical and chemical characteristics of thousands of cells per second, offering high precision and efficiency. Innovations in flow cytometry technology, such as the introduction of advanced multicolor flow cytometers, improved reagents, and software enhancements, have further strengthened its adoption across academic, clinical, and pharmaceutical research settings. Additionally, the increasing demand for personalized medicine and targeted therapies has amplified the need for advanced single-cell analysis techniques, thereby boosting the growth of this segment. The rising focus on stem cell research, cancer immunotherapy, and infectious disease diagnosis continues to support the expansion of the flow cytometry market. As a result, the flow cytometry segment is expected to maintain its leadership position in the coming years.

North America dominated the single-cell analysis market in 2024.

The global single-cell analysis market is segmented into six major regions—North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. North America accounted for the largest share of the single-cell analysis market in 2024, followed by Europe and the Asia Pacific region. Within North America, the US contributes the largest share at the country level, owing to several key factors. These include the strong presence of major market players, a robust focus on pharmaceutical and biotechnology research and development (R&D), and continuous advancements in healthcare infrastructure. Moreover, the increasing development and commercialization of cell-based therapies and substantial investments in R&D activities have further fueled market growth. The presence of a well-established healthcare system, along with favorable government initiatives and funding for scientific research, also plays a critical role. Various renowned research institutes and academic centers in the region are actively engaged in advancing single-cell technologies, supporting the expansion of this market. For example, in January 2025, researchers from St. Jude Children's Research Hospital developed an innovative machine-learning tool known as CSI-GEP, designed to enhance the analysis of large single-cell gene expression datasets, highlighting the region’s commitment to technological innovation and scientific excellence.

HIGHEST CAGR MARKET IN 2025–2030
US IS THE FASTEST-GROWING MARKET IN THE REGION
Single-Cell Analysis Market

Recent Developments of Single-Cell Analysis Market

  • In November 2024, 10x Genomics (US) and Hamilton Company (US) entered into a partnership to develop an automated, high-throughput solution for single-cell experiments. Through the partnership, these companies aim to streamline single-cell library preparation workflows, enabling researchers to process up to 96 single-cell samples simultaneously, accelerating discoveries, and simplifying complex workflows.
  • In October 2024, BD (US) launched BD OMICS-One XT WTA Assay, a high-throughput, robotics-compatible reagent kit in collaboration with Hamilton Company (US). This solution reduces manual processes, improves consistency, minimizes variability, and accelerates large-scale single-cell discovery studies in areas like oncology and immunology.
  • In October 2024, Illumina introduced the MiSeq i100 Series sequencing systems, designed to make next-generation sequencing (NGS) faster, simpler, and more accessible for laboratories.
  • In October 2024, 10x Genomics unveiled two new Chromium products, GEM-X Flex and GEM-X Universal Multiplex, to enhance accessibility and affordability in single-cell analysis for researchers.

Key Market Players

Want to explore hidden markets that can drive new revenue in Single Cell Analysis Market?

Scope of the Report

Report Metric Details
Market size available for years 2023-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD)
Segments covered Product, Cell Type, Technique, Application, and End User
Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Key Questions Addressed by the Report

Who are the key players in the single-cell analysis market?
Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), 10X Genomics (US), and BD (US).
Which product segment dominates the single-cell analysis market?
The consumables segment, due to the increasing need for high-quality reagents for developing advanced biotherapeutic products.
Which cell type segment is expected to witness the highest growth?
The human cells segment, driven by the rising demand for cell-based therapies and the prevalence of chronic diseases.
Which application segment is expected to register the highest growth?
The research applications segment, fueled by the increasing need for advanced biotherapeutics.
What is the size of the single-cell analysis market?
Expected to grow at a CAGR of 14.7%, from approximately USD 3.81 billion in 2025 to USD 7.56 billion by 2030.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Single Cell Analysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
47
RESEARCH METHODOLOGY
52
EXECUTIVE SUMMARY
64
PREMIUM INSIGHTS
68
MARKET OVERVIEW
71
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Technological advancements in single-cell analysis products
    - Rising prevalence of cancer
    - Increasing R&D in pharmaceutical and biotechnology industries
    - Growth in stem cell research
    - Growing focus on personalized medicine
    RESTRAINTS
    - High cost of single-cell analysis products
    OPPORTUNITIES
    - High growth potential of single-cell sequencing
    - Integration of microfluidics in single-cell analysis
    - Rising potential in emerging Asian markets
    CHALLENGES
    - Lack of standardization in protocols and quality control procedures
    - Technical limitations of single-cell analysis
    - Mounting ethical and privacy concerns
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Flow cytometry
    - Next-generation sequencing
    - Polymerase chain reaction
    - Microscopy
    - Mass spectrometry
    COMPLEMENTARY TECHNOLOGIES
    - Bioinformatics tools and computational analysis
    - Multi-omics integration
    ADJACENT TECHNOLOGIES
    - Nanotechnology
    - Artificial intelligence and machine learning
  • 5.7 PATENT ANALYSIS
    METHODOLOGY
    PATENTS APPLIED AND GRANTED, 2014–2024
  • 5.8 TRADE ANALYSIS
    IMPORT DATA (HS CODE 9027)
    EXPORT DATA (HS CODE 9027)
  • 5.9 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 TARIFF & REGULATORY LANDSCAPE
    TARIFF DATA (HS CODE 9027)
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
  • 5.11 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS
    AVERAGE SELLING PRICE OF PRODUCTS, BY REGION
  • 5.12 KEY CONFERENCES AND EVENTS, 2025–2026
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    ROLE OF STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.14 INVESTMENT AND FUNDING SCENARIO
  • 5.15 IMPACT OF GENERATIVE AI ON SINGLE-CELL ANALYSIS MARKET
    AI USE-CASES
    KEY COMPANIES IMPLEMENTING AI
  • 5.16 CASE STUDY ANALYSIS
    COMPREHENSIVE SINGLE-CELL TRANSCRIPTOMIC ATLAS OF HUMAN CORNEA
    MASSIVELY PARALLEL SINGLE-CELL RNA SEQUENCING IDENTIFIES RARE DRUG-RESISTANT CANCER SUBPOPULATIONS
    SINGLE-CELL ANALYSIS OF RENAL CELL CARCINOMA REVEALS TUMOR HETEROGENEITY AND MICROENVIRONMENTAL COMPLEXITY
  • 5.17 US 2025 TARIFF IMPACT OVERVIEW
    INTRODUCTION
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    KEY IMPACT ON VARIOUS REGIONS
    - US
    - Europe
    - Asia Pacific
    - Rest of the World
    END-USE INDUSTRY IMPACT
    - Pharmaceutical and biotech companies
    - Contract research organizations (CROs)
    - Academic & research institutes
SINGLE-CELL ANALYSIS MARKET, BY APPLICATION
122
  • 6.1 INTRODUCTION
  • 6.2 RESEARCH APPLICATIONS
    CANCER RESEARCH
    - Rising prevalence of cancer to drive market
    IMMUNOLOGY RESEARCH
    - High incidence of immunological disorders to propel market
    NEUROLOGY RESEARCH
    - Increasing incidence of neurological disorders to boost market
    STEM CELL RESEARCH
    - Rising investments in stem cell research to drive market
    OTHER RESEARCH APPLICATIONS
  • 6.3 MEDICAL APPLICATIONS
    NON-INVASIVE PRENATAL DIAGNOSIS
    - Increasing prevalence of genetic diseases to drive demand
    IN VITRO FERTILIZATION
    - Growing demand for IVF procedures to support market
    CIRCULATING TUMOR CELL DETECTION
    - Rising prevalence of cancer to contribute to segment growth
SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE
155
  • 7.1 INTRODUCTION
  • 7.2 HUMAN CELLS
    GROWING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND
  • 7.3 ANIMAL CELLS
    INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET
  • 7.4 MICROBIAL CELLS
    RISING GOVERNMENT SUPPORT TO COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET
SINGLE-CELL ANALYSIS MARKET, BY END USER
166
  • 8.1 INTRODUCTION
  • 8.2 ACADEMIC & RESEARCH LABORATORIES
    INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET
  • 8.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
    GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO BOOST MARKET
  • 8.4 HOSPITALS & DIAGNOSTIC LABORATORIES
    HIGH PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES TO DRIVE DEMAND
  • 8.5 CELL BANKS & IVF CENTERS
    RISING DEMAND FOR PERSONALIZED AND REGENERATIVE MEDICINE TO PROPEL MARKET
SINGLE-CELL ANALYSIS MARKET, BY PRODUCT
182
  • 9.1 INTRODUCTION
  • 9.2 CONSUMABLES
    BEADS
    - Increasing use in research and genetic exploration to drive market
    MICROPLATES
    - Rising frequency of product launches to boost market
    REAGENTS
    - Advancements in single-cell genomics to increase demand
    ASSAY KITS
    - Immunoassays
    - Cell-based assays
    OTHER CONSUMABLES
  • 9.3 INSTRUMENTS
    FLOW CYTOMETERS
    - Technological advancements to drive demand
    NGS SYSTEMS
    - Increased affordability to support segment growth
    PCR INSTRUMENTS
    - Rising use for DNA and mRNA amplification to boost market
    SPECTROPHOTOMETERS
    - Technological advancements to boost market
    CELL COUNTERS
    - Rising demand for automated cell counters to fuel market
    MICROSCOPES
    - Increasing use in cell-based research to drive market
    HCS SYSTEMS
    - Growing need for multi-parametric cell analysis to drive adoption
    MICROARRAYS
    - Increasing development of targeted therapies to support market
    OTHER INSTRUMENTS
SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE
236
  • 10.1 INTRODUCTION
  • 10.2 FLOW CYTOMETRY
    INCREASING USE TO IDENTIFY CANCEROUS CELLS TO DRIVE MARKET
  • 10.3 NEXT-GENERATION SEQUENCING
    WIDE ADOPTION IN DRUG DISCOVERY TO DRIVE MARKET
  • 10.4 POLYMERASE CHAIN REACTION
    INCREASING APPLICATIONS OF DIGITAL PCR TO SUPPORT MARKET
  • 10.5 MICROSCOPY
    FOCUS ON DEVELOPMENT OF ADVANCED IMAGING SYSTEMS TO PROPEL MARKET
  • 10.6 MASS SPECTROMETRY
    LAUNCH OF ADVANCED PRODUCTS TO DRIVE MARKET
  • 10.7 OTHER TECHNIQUES
SINGLE-CELL ANALYSIS MARKET, BY REGION
257
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Increasing R&D investments and funding to drive market
    CANADA
    - High prevalence of hemophilia to propel market
  • 11.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Growing awareness of advanced cell therapies to support market
    UK
    - Growing adoption of single-cell analysis products to drive demand
    FRANCE
    - Growing government funding for R&D to propel market
    ITALY
    - Focus on cell biology research to drive market
    SPAIN
    - Increasing number of biotechnology companies to drive demand
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Increasing R&D expenditure to support market
    JAPAN
    - Increasing geriatric population to fuel demand
    INDIA
    - Growing focus on development of cell-based therapies to boost market
    SOUTH KOREA
    - Increasing number of strategic alliances to boost market
    AUSTRALIA
    - Rising number of life science companies to boost demand
    REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Rising focus on biotechnology industry to bolster market
    MEXICO
    - Government support for biopharmaceutical production to drive market
    REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST
    MACROECONOMIC OUTLOOK IN MIDDLE EAST
    GCC
    - Saudi Arabia
    - United Arab Emirates
    - Rest of GCC
    REST OF MIDDLE EAST
  • 11.7 AFRICA
    GROWING FUNDING FOR DEVELOPMENT AND PRODUCTION OF BIOPHARMACEUTICALS TO DRIVE MARKET
    MACROECONOMIC OUTLOOK FOR AFRICA
COMPETITIVE LANDSCAPE
381
  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025
  • 12.3 REVENUE ANALYSIS, 2022–2024
  • 12.4 MARKET SHARE ANALYSIS, 2024
    RANKING OF KEY MARKET PLAYERS
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Product footprint
    - Region footprint
    - Technique footprint
    - Application footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 12.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
408
  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYERS
    BD
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    DANAHER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    10X GENOMICS
    - Business overview
    - Products offered
    - Recent developments
    MERCK KGAA
    - Business overview
    - Products offered
    - Recent developments
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products offered
    - Recent developments
    QIAGEN
    - Business overview
    - Products offered
    - Recent developments
    ILLUMINA, INC.
    - Business overview
    - Products offered
    - Recent developments
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products offered
    - Recent developments
    DIASORIN S.P.A.
    - Business overview
    - Products offered
    - Recent developments
    STANDARD BIOTOOLS
    - Business overview
    - Product offered
    - Recent developments
    TECAN TRADING AG
    - Business overview
    - Products offered
    - Recent developments
    SARTORIUS AG
    - Business overview
    - Products offered
    - Recent developments
    CORNING INCORPORATED
    - Business overview
    - Products offered
    CYTEK BIOSCIENCES
    - Business overview
    - Products offered
    - Recent developments
    TAKARA BIO INC.
    - Business overview
    - Products offered
    - Recent developments
    BIOMÉRIEUX
    - Business overview
    - Products offered
    - Recent developments
    REVVITY
    - Business overview
    - Products offered
    - Recent developments
    BIO-TECHNE
    - Business overview
    - Products offered
    - Recent developments
    PACBIO
    - Business overview
    - Products offered
    - Recent developments
    BRUKER
    - Business overview
    - Products offered
    - Recent developments
    PROMEGA CORPORATION
    - Business overview
    - Products offered
    OXFORD NANOPORE TECHNOLOGIES PLC
    - Business overview
    - Products offered
    - Recent developments
  • 13.3 OTHER PLAYERS
    SINGLERON BIOTECHNOLOGIES
    CELL MICROSYSTEMS
    NANOCELLECT BIOMEDICAL
    RARECYTE, INC.
    BICO
    MENARINI GROUP
    APOGEE FLOW SYSTEMS LTD
    CREATIVE BIOLABS
    SPHERE BIO
    YOKOGAWA ELECTRIC CORPORATION
DISCUSSION GUIDE
508
  • 14.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.2 CUSTOMIZATION OPTIONS
  • 14.3 RELATED REPORTS
  • 14.4 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 2 SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS
  • TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND PRODUCT LAUNCHES
  • TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035
  • TABLE 5 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION)
  • TABLE 6 ESTIMATED EXPENDITURE BY NIH FOR STEM CELL RESEARCH, 2019–2025
  • TABLE 7 SINGLE-CELL ANALYSIS MARKET: RAW MATERIAL VENDORS
  • TABLE 8 SINGLE-CELL ANALYSIS MARKET: PRODUCT VENDORS
  • TABLE 9 SINGLE-CELL ANALYSIS MARKET: END USERS
  • TABLE 10 SINGLE-CELL ANALYSIS MARKET: REGULATORY BODIES
  • TABLE 11 APPLICATIONS OF MICROSCOPIC TECHNIQUES IN SINGLE-CELL ANALYSIS
  • TABLE 12 TYPES OF BIOINFORMATICS TOOLS
  • TABLE 13 PATENTS FILED, 2014–2024
  • TABLE 14 INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024
  • TABLE 15 IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSAND)
  • TABLE 16 IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS)
  • TABLE 17 EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSAND)
  • TABLE 18 EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS)
  • TABLE 19 SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 SINGLE-CELL ANALYSIS MARKET: REGULATORY GUIDELINES
  • TABLE 25 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS, 2022–2024
  • TABLE 26 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
  • TABLE 27 SINGLE-CELL ANALYSIS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
  • TABLE 28 BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS, BY END USER
  • TABLE 29 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 30 KEY PRODUCT-RELATED TARIFF: MISCELLANEOUS CHEMICAL PRODUCTS AND ELECTRICAL MACHINERY AND EQUIPMENT AND PARTS THEREOF
  • TABLE 31 CRITICAL COMPONENTS EXPOSED TO TARIFF CHANGES
  • TABLE 32 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 33 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 34 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 35 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 36 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 38 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 39 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 40 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 41 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 42 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 43 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 44 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 45 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 46 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 47 GCC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 48 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 49 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 50 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 52 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 54 GCC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 55 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 56 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 57 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 58 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 59 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 60 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 61 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 62 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 64 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 66 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 67 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 68 GCC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 69 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 70 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 71 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 73 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 74 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 75 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 76 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 77 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 79 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 81 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 82 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 83 GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 84 SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 85 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 86 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 87 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 88 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 89 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 90 GCC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 91 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 92 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 93 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 95 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 96 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 97 GCC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 98 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 99 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 100 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 102 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 103 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 104 GCC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 105 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 106 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 107 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 108 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 110 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 111 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 112 GCC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 113 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 114 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 115 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 117 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 118 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 119 GCC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 120 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 121 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 122 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 124 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 125 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 126 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 127 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 128 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 129 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 130 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 132 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 133 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 134 GCC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 135 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 136 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 137 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 139 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 140 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 141 GCC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 142 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 143 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 144 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 146 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 147 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 148 GCC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 149 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 150 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 151 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 153 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 154 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 155 GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 156 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 157 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 158 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 159 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 160 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 162 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 163 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 164 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 165 SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 166 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 167 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 169 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 170 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 171 GCC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 172 SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 173 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 174 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 175 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 176 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 177 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 178 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 179 SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 180 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 181 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 183 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 184 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 185 GCC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 186 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 187 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 188 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 189 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 191 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 192 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 193 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 194 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 195 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 196 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 197 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 198 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 199 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 200 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 201 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 202 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 203 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 204 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 205 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 206 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 207 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 208 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 209 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 210 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 211 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 212 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 213 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES,BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 214 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 215 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 216 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 217 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 218 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 220 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 221 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 222 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 223 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 224 NORTH AMERICA: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 225 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 226 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 227 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 228 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS,BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 229 GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 230 SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 231 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 232 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 233 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 234 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 235 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 236 GCC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 237 SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 238 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 239 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 240 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 241 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 242 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 243 GCC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 244 SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 245 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 246 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 248 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 249 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 250 GCC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 251 SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 252 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 253 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 254 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 255 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 256 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 257 GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 258 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 259 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 260 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 261 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 262 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 263 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 264 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 265 SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 266 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 267 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 268 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 269 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 270 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 271 GCC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 272 SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 273 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 274 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 275 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 276 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 277 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 278 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 279 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 280 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 281 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 282 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 283 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 284 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 285 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 286 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 287 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 288 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 289 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 290 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 291 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 292 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY,BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 293 GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 294 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 295 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 296 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 297 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 298 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 299 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 300 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING,BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 301 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 302 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 303 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION,BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 304 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 305 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 306 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 307 GCC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 308 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 309 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 310 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 311 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 312 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 313 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 314 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 315 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 316 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 317 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 318 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 319 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 320 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 321 GCC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 322 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 323 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 324 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 325 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 326 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 327 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES,BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 328 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 329 SINGLE-CELL ANALYSIS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 330 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 331 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 332 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 333 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 334 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 335 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 336 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 337 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 338 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 339 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 340 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 341 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 342 US: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 343 US: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 344 US: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 345 US: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 346 US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 347 US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 348 US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 349 US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 350 US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 351 US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 352 CANADA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 353 CANADA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 354 CANADA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 355 CANADA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 356 CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 357 CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 358 CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 359 CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 360 CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 361 CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 362 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 363 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 364 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 365 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 366 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 367 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 368 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 369 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 370 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 371 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 372 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 373 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 374 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 375 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 376 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 377 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 378 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 379 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 380 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 381 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 382 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 383 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 384 UK: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 385 UK: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 386 UK: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 387 UK: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 388 UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 389 UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 390 UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 391 UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 392 UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 393 UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 394 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 395 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 396 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 397 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 398 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 399 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 400 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 401 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 402 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 403 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 404 ITALY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 405 ITALY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 406 ITALY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 407 ITALY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 408 ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 409 ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 410 ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 411 ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 412 ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 413 ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 414 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 415 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,2023–2030 (USD MILLION)
  • TABLE 416 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 417 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 418 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 419 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 420 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 421 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 422 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 423 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 424 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 425 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 426 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 427 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 428 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 429 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 430 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 431 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 432 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 433 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 434 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 435 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 436 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 437 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 438 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 439 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 440 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 441 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 442 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 443 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 444 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 445 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 446 CHINA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 447 CHINA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 448 CHINA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 449 CHINA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 450 CHINA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 451 CHINA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 452 CHINA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 453 CHINA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 454 CHINA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 455 CHINA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 456 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 457 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 458 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 459 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 460 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 461 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 462 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 463 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 464 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 465 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 466 INDIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 467 INDIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 468 INDIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 469 INDIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 470 INDIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 471 INDIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 472 INDIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 473 INDIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 474 INDIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 475 INDIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 476 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 477 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 478 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,2023–2030 (USD MILLION)
  • TABLE 479 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 480 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 481 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 482 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 483 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 484 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 485 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 486 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 487 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 488 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 489 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 490 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 491 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 492 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 493 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 494 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 495 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 496 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 497 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 498 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 499 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 500 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 501 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 502 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 503 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 504 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 505 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 506 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 507 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 508 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 509 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 510 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 511 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 512 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 513 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 514 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 515 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 516 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 517 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 518 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 519 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 520 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 521 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 522 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 523 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 524 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 525 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 526 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 527 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 528 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 529 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 530 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 531 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 532 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 533 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 534 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 535 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 536 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 537 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 538 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 539 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 540 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 541 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 542 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 543 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 544 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 545 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 546 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 547 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 548 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 549 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 550 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 551 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 552 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 553 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 554 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 555 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 556 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 557 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 558 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 559 MIDDLE EAST: MACROECONOMIC INDICATORS
  • TABLE 560 GCC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 561 GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 562 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 563 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 564 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 565 GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 566 GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 567 GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,2023–2030 (USD MILLION)
  • TABLE 568 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 569 GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 570 GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 571 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 572 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 573 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 574 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 575 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 576 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 577 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 578 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 579 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 580 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 581 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 582 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 583 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 584 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 585 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 586 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 587 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 588 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 589 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 590 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 591 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 592 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 593 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 594 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 595 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 596 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 597 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 598 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 599 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 600 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 601 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 602 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 603 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 604 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 605 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 606 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 607 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 608 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 609 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 610 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 611 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 612 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 613 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 614 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 615 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
  • TABLE 616 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
  • TABLE 617 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 618 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 619 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 620 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 621 MACROECONOMIC OUTLOOK FOR AFRICA
  • TABLE 622 SINGLE-CELL ANALYSIS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2025
  • TABLE 623 SINGLE-CELL ANALYSIS MARKET: DEGREE OF COMPETITION
  • TABLE 624 SINGLE-CELL ANALYSIS MARKET: PRODUCT FOOTPRINT
  • TABLE 625 SINGLE-CELL ANALYSIS MARKET: REGION FOOTPRINT
  • TABLE 626 SINGLE-CELL ANALYSIS MARKET: TECHNIQUE FOOTPRINT
  • TABLE 627 SINGLE-CELL ANALYSIS MARKET: APPLICATION FOOTPRINT
  • TABLE 628 SINGLE-CELL ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 629 SINGLE-CELL ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 630 SINGLE-CELL ANALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 631 SINGLE-CELL ANALYSIS MARKET: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 632 SINGLE-CELL ANALYSIS MARKET: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 633 BD: COMPANY OVERVIEW
  • TABLE 634 BD: PRODUCTS OFFERED
  • TABLE 635 BD: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 636 BD: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 637 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 638 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 639 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 640 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 641 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 642 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 643 DANAHER CORPORATION: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 644 10X GENOMICS: COMPANY OVERVIEW
  • TABLE 645 10X GENOMICS: PRODUCTS OFFERED
  • TABLE 646 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 647 10X GENOMICS: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 648 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 649 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 650 MERCK KGAA: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 651 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 652 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
  • TABLE 653 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 654 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 655 QIAGEN: COMPANY OVERVIEW
  • TABLE 656 QIAGEN: PRODUCTS OFFERED
  • TABLE 657 QIAGEN: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 658 ILLUMINA, INC.: COMPANY OVERVIEW
  • TABLE 659 ILLUMINA, INC.: PRODUCTS OFFERED
  • TABLE 660 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 661 ILLUMINA, INC.: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 662 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 663 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 664 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 665 DIASORIN S.P.A.: COMPANY OVERVIEW
  • TABLE 666 DIASORIN S.P.A.: PRODUCTS OFFERED
  • TABLE 667 DIASORIN S.P.A.: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 668 STANDARD BIOTOOLS: COMPANY OVERVIEW
  • TABLE 669 STANDARD BIOTOOLS: PRODUCTS OFFERED
  • TABLE 670 STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 671 STANDARD BIOTOOLS: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 672 TECAN TRADING AG: COMPANY OVERVIEW
  • TABLE 673 TECAN TRADING AG: PRODUCTS OFFERED
  • TABLE 674 TECAN TRADING AG: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 675 TECAN TRADING AG: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 676 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 677 SARTORIUS AG: PRODUCTS OFFERED
  • TABLE 678 SARTORIUS AG: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 679 SARTORIUS AG: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 680 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 681 CORNING INCORPORATED: PRODUCTS OFFERED
  • TABLE 682 CYTEK BIOSCIENCES: COMPANY OVERVIEW
  • TABLE 683 CYTEK BIOSCIENCES: PRODUCTS OFFERED
  • TABLE 684 CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 685 CYTEK BIOSCIENCES: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 686 CYTEK BIOSCIENCES: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 687 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 688 TAKARA BIO INC.: PRODUCTS OFFERED
  • TABLE 689 TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 690 TAKARA BIO INC.: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 691 BIOMÉRIEUX: COMPANY OVERVIEW
  • TABLE 692 BIOMÉRIEUX: PRODUCTS OFFERED
  • TABLE 693 BIOMÉRIEUX: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 694 REVVITY: COMPANY OVERVIEW
  • TABLE 695 REVVITY: PRODUCTS OFFERED
  • TABLE 696 REVVITY: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 697 BIO-TECHNE: COMPANY OVERVIEW
  • TABLE 698 BIO-TECHNE: PRODUCTS OFFERED
  • TABLE 699 BIO-TECHNE: DEALS
  • TABLE 700 PACBIO: COMPANY OVERVIEW
  • TABLE 701 PACBIO: PRODUCTS OFFERED
  • TABLE 702 PACBIO: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 703 BRUKER: COMPANY OVERVIEW
  • TABLE 704 BRUKER: PRODUCTS OFFERED
  • TABLE 705 BRUKER: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 706 BRUKER: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 707 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 708 PROMEGA CORPORATION: PRODUCTS OFFERED
  • TABLE 709 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
  • TABLE 710 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS OFFERED
  • TABLE 711 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 712 SINGLERON BIOTECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 713 CELL MICROSYSTEMS: COMPANY OVERVIEW
  • TABLE 714 NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW
  • TABLE 715 RARECYTE, INC.: COMPANY OVERVIEW
  • TABLE 716 BICO: COMPANY OVERVIEW
  • TABLE 717 MENARINI GROUP: COMPANY OVERVIEW
  • TABLE 718 APOGEE FLOW SYSTEMS LTD: COMPANY OVERVIEW
  • TABLE 719 CREATIVE BIOLABS: COMPANY OVERVIEW
  • TABLE 720 SPHERE BIO: COMPANY OVERVIEW
  • TABLE 721 YOKOGAWA ELECTRIC CORPORATION: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 SINGLE-CELL ANALYSIS MARKET: RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARIES: SINGLE-CELL ANALYSIS MARKET
  • FIGURE 3 SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024
  • FIGURE 5 ILLUSTRATIVE EXAMPLE OF BD COMPANY: REVENUE ANALYSIS, 2024
  • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 8 SINGLE-CELL ANALYSIS MARKET: CAGR PROJECTIONS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 11 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 GEOGRAPHIC SNAPSHOT OF SINGLE-CELL ANALYSIS MARKET
  • FIGURE 16 GROWTH IN STEM CELL RESEARCH TO DRIVE MARKET
  • FIGURE 17 HUMAN CELLS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2024
  • FIGURE 18 CONSUMABLES SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE IN 2025
  • FIGURE 19 ACADEMIC & RESEARCH LABORATORIES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD
  • FIGURE 21 SINGLE-CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 AGE-STANDARDIZED RATE (WORLD) PER 100,000 CANCER INCIDENCES IN MEN AND WOMEN, 2022
  • FIGURE 23 WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND, 2014–2028
  • FIGURE 24 SHARE OF PERSONALIZED MEDICINE IN FDA'S NEW DRUG APPROVALS, 2015–2023
  • FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 26 SINGLE-CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 27 SINGLE-CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 PATENT APPLICATIONS IN SINGLE-CELL ANALYSIS MARKET, JANUARY 2014–DECEMBER 2024
  • FIGURE 29 SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-CELL ANALYSIS PRODUCTS
  • FIGURE 31 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 32 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, 2023–2030 (THOUSAND UNITS)
  • FIGURE 33 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SNAPSHOT
  • FIGURE 34 NIH FUNDING FOR STEM CELL RESEARCH, 2015–2025
  • FIGURE 35 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET SNAPSHOT
  • FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET, 2022–2024
  • FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
  • FIGURE 38 RANKING OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET, 2024
  • FIGURE 39 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 40 SINGLE-CELL ANALYSIS MARKET: COMPANY FOOTPRINT
  • FIGURE 41 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2023
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 SINGLE-CELL ANALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 45 BD: COMPANY SNAPSHOT (2024)
  • FIGURE 46 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 48 10X GENOMICS: COMPANY SNAPSHOT (2024)
  • FIGURE 49 MERCK KGAA: COMPANY SNAPSHOT (2024)
  • FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 51 QIAGEN: COMPANY SNAPSHOT (2024)
  • FIGURE 52 ILLUMINA, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 54 DIASORIN S.P.A.: COMPANY SNAPSHOT (2024)
  • FIGURE 55 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2024)
  • FIGURE 56 TECAN TRADING AG: COMPANY SNAPSHOT (2024)
  • FIGURE 57 SARTORIUS AG: COMPANY SNAPSHOT (2024)
  • FIGURE 58 CORNING INCORPORATED: COMPANY SNAPSHOT (2024)
  • FIGURE 59 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2024)
  • FIGURE 60 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 61 BIOMÉRIEUX: COMPANY SNAPSHOT (2024)
  • FIGURE 62 REVVITY: COMPANY SNAPSHOT (2024)
  • FIGURE 63 BIO-TECHNE: COMPANY SNAPSHOT (2023)
  • FIGURE 64 PACBIO: COMPANY SNAPSHOT (2024)
  • FIGURE 65 BRUKER: COMPANY SNAPSHOT (2024)
  • FIGURE 66 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2024)

 

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-cell analysis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-cell analysis market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), International Clinical Cytometry Society (ICCS), International Society for Advancement of Cytometry (ISAC), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), and Society for Laboratory Automation and Screening (SLAS), Statista; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global single-cell analysis market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, cell banks, and IVF centers, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, including the Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Single-Cell Analysis Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell analysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the single-cell analysis business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Top-down Approach

  • After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Single-Cell Analysis Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Single-cell analysis is a method for examining individual cells across various parameters, particularly beneficial when dealing with diverse cell populations. This approach focuses on studying a single cell isolated from tissues in a multicellular organism. Technologies including flow cytometry and microfluidics are used for single-cell analysis purpose. Such analysis facilitates the exploration of variations between cells within a population. Currently, single-cell analysis finds extensive applications in cancer research, immunology, stem cell research, and neurobiology.

Stakeholders

  • Single-cell analysis product manufacturers, vendors, and distributors
  • Academic and research laboratories
  • Pharmaceutical and biopharmaceutical companies
  • Venture capitalists and investors
  • Government organizations
  • Private research firms
  • Cell Banks & IVF centers
  • Hospitals & diagnostic centers

Report Objectives

  • To define, describe, segment, and forecast the single-cell analysis market by product, cell type, technique, application, end user, and region
  • To provide detailed information about the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall single-cell analysis market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments concerning six main regions: North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa
  • To strategically profile the key players in the global single-cell analysis market and comprehensively analyze their core competencies2 and market rankings
  • To track and analyze competitive developments in the single-cell analysis market, such as product launches, acquisitions, collaborations, expansions, and partnerships
  • To benchmark players within the single-cell analysis market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business excellence and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies.
Company Information
  • Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
  • A further breakdown of the Rest of Europe  single-cell analysis market into countries
  • A further breakdown of the Rest of Asia Pacific single-cell analysis market into countries
  • A further breakdown of the Rest of Latin American single-cell analysis market into countries
  • A further breakdown of the Rest of Middle East single-cell analysis market into countries

Previous Versions of this Report

Single cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) & Region - Global Forecast to 2029

Report Code BT 4224
Published in Aug, 2024, By MarketsandMarkets™

Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) - Global Forecast to 2028

Report Code BT 4224
Published in Jun, 2023, By MarketsandMarkets™

Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, PCR, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) - Global Forecast to 2026

Report Code BT 4224
Published in Sep, 2021, By MarketsandMarkets™

Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instruments), Technique (Flow Cytometry, NGS, PCR, Mass Spectrometry, Microscopy), Application (Research, Medical Application), End User - Global Forecasts to 2025

Report Code BT 4224
Published in Feb, 2020, By MarketsandMarkets™

Single-cell Analysis Market by Product (Consumables and Instruments), Cell Type (Human and Animal), Technique (Flow Cytometry, NGS, PCR, and Mass Spectrometry), Application (Cancer, Neurology, NIPD, IVF, and CTCs), End User - Global Forecasts to 2022

Report Code BT 4224
Published in Jun, 2017, By MarketsandMarkets™

Single-Cell Analysis Market by Product (Beads, Microplate, Reagents, Flow Cytometer, Microscope, Spectrophotometer), Cell Type (Human, Animal), Technique (NGS, PCR), Application (Cancer, Neurology, NIPD, IVF, CTCs) & End User - Global Forecasts to 2021

Report Code BT 4224
Published in Apr, 2016, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Single Cell Analysis Market

DMCA.com Protection Status